Clinical trial
Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating…
NCT00025636 · German Hodgkin's Lymphoma Study Group, Other · Unknown status
Key facts
| NCT number | NCT00025636 |
|---|---|
| Title | Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma |
| Official title | A Randomized Trial Of BEAM Plus PBSCT Versus Single Agent High-Dose Therapy Followed By BEAM Plus PBSCT In Patients With Relapsed Hodgkin's Disease |
| Lead sponsor | German Hodgkin's Lymphoma Study Group, Other |
| Collaborators | European Organisation for Research and Treatment of Cancer - EORTC EBMT Solid Tumors Working Party |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, carmustine, cisplatin, cyclophosphamide, cytarabine, dexamethasone, etoposide, melphalan, methotrexate, vincristine sulfate and 2 more |
| Enrollment | 220 |
| Start date | Jul 1, 2001 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 17, 2013 |
| Countries | Belgium, Croatia, Denmark, Germany, Netherlands, Poland, Portugal, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: